Jazz Pharmaceuticals (JAZZ) Cash from Investing Activities (QoQ) (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Jazz Pharmaceuticals | 15.75 Bn | 13.91 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 133.08% |
| Dec 31, 2025 | -13.53% |
| Sep 30, 2025 | 48.86% |
| Jun 30, 2025 | -279.26% |
| Mar 31, 2025 | 12.57% |
| Dec 31, 2024 | -190.28% |
| Sep 30, 2024 | 183.27% |
| Jun 30, 2024 | 5.45% |
| Mar 31, 2024 | -367.10% |
| Dec 31, 2023 | 158.40% |
| Sep 30, 2023 | -103.29% |
| Jun 30, 2023 | -1,678.08% |
| Mar 31, 2023 | 98.51% |
| Dec 31, 2022 | -7,148.63% |
| Sep 30, 2022 | 105.16% |
| Jun 30, 2022 | -139.09% |
| Mar 31, 2022 | -269.52% |
| Dec 31, 2021 | 62.36% |
| Sep 30, 2021 | 99.55% |
| Jun 30, 2021 | -902.08% |